nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Hypoxemia—Methotrexate—psoriatic arthritis	0.0401	0.0401	CcSEcCtD
Cisatracurium Besylate—Trauma—Prednisolone—psoriatic arthritis	0.0278	0.0278	CcSEcCtD
Cisatracurium Besylate—Trauma—Triamcinolone—psoriatic arthritis	0.0256	0.0256	CcSEcCtD
Cisatracurium Besylate—Trauma—Methylprednisolone—psoriatic arthritis	0.0255	0.0255	CcSEcCtD
Cisatracurium Besylate—Trauma—Dexamethasone—psoriatic arthritis	0.0232	0.0232	CcSEcCtD
Cisatracurium Besylate—Trauma—Betamethasone—psoriatic arthritis	0.0232	0.0232	CcSEcCtD
Cisatracurium Besylate—Trauma—Prednisone—psoriatic arthritis	0.0202	0.0202	CcSEcCtD
Cisatracurium Besylate—Myopathy—Prednisolone—psoriatic arthritis	0.0189	0.0189	CcSEcCtD
Cisatracurium Besylate—Myopathy—Triamcinolone—psoriatic arthritis	0.0174	0.0174	CcSEcCtD
Cisatracurium Besylate—Myopathy—Methylprednisolone—psoriatic arthritis	0.0173	0.0173	CcSEcCtD
Cisatracurium Besylate—Angioedema—Auranofin—psoriatic arthritis	0.0166	0.0166	CcSEcCtD
Cisatracurium Besylate—Myopathy—Betamethasone—psoriatic arthritis	0.0158	0.0158	CcSEcCtD
Cisatracurium Besylate—Myopathy—Dexamethasone—psoriatic arthritis	0.0158	0.0158	CcSEcCtD
Cisatracurium Besylate—Azotaemia—Methotrexate—psoriatic arthritis	0.0151	0.0151	CcSEcCtD
Cisatracurium Besylate—Myopathy—Prednisone—psoriatic arthritis	0.0137	0.0137	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Methotrexate—psoriatic arthritis	0.0127	0.0127	CcSEcCtD
Cisatracurium Besylate—Wheezing—Triamcinolone—psoriatic arthritis	0.0118	0.0118	CcSEcCtD
Cisatracurium Besylate—Urticaria—Auranofin—psoriatic arthritis	0.0118	0.0118	CcSEcCtD
Cisatracurium Besylate—Pruritus—Auranofin—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Cisatracurium Besylate—Injury—Prednisolone—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Prednisolone—psoriatic arthritis	0.00993	0.00993	CcSEcCtD
Cisatracurium Besylate—Injury—Triamcinolone—psoriatic arthritis	0.00962	0.00962	CcSEcCtD
Cisatracurium Besylate—Injury—Methylprednisolone—psoriatic arthritis	0.0096	0.0096	CcSEcCtD
Cisatracurium Besylate—Rash—Auranofin—psoriatic arthritis	0.00935	0.00935	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Auranofin—psoriatic arthritis	0.00934	0.00934	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00914	0.00914	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Triamcinolone—psoriatic arthritis	0.00914	0.00914	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methylprednisolone—psoriatic arthritis	0.00912	0.00912	CcSEcCtD
Cisatracurium Besylate—Injury—Dexamethasone—psoriatic arthritis	0.00873	0.00873	CcSEcCtD
Cisatracurium Besylate—Injury—Betamethasone—psoriatic arthritis	0.00873	0.00873	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Prednisolone—psoriatic arthritis	0.00848	0.00848	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00841	0.00841	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.00839	0.00839	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Betamethasone—psoriatic arthritis	0.00829	0.00829	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Dexamethasone—psoriatic arthritis	0.00829	0.00829	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Triamcinolone—psoriatic arthritis	0.0078	0.0078	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00778	0.00778	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00763	0.00763	CcSEcCtD
Cisatracurium Besylate—Injury—Prednisone—psoriatic arthritis	0.0076	0.0076	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.0075	0.0075	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00708	0.00708	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Betamethasone—psoriatic arthritis	0.00708	0.00708	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisolone—psoriatic arthritis	0.00677	0.00677	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Prednisone—psoriatic arthritis	0.00664	0.00664	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Triamcinolone—psoriatic arthritis	0.00623	0.00623	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00621	0.00621	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Prednisone—psoriatic arthritis	0.00616	0.00616	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methotrexate—psoriatic arthritis	0.00603	0.00603	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.006	0.006	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisolone—psoriatic arthritis	0.00579	0.00579	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Dexamethasone—psoriatic arthritis	0.00565	0.00565	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Betamethasone—psoriatic arthritis	0.00565	0.00565	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methylprednisolone—psoriatic arthritis	0.00554	0.00554	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00551	0.00551	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.0055	0.0055	CcSEcCtD
Cisatracurium Besylate—Erythema—Triamcinolone—psoriatic arthritis	0.00533	0.00533	CcSEcCtD
Cisatracurium Besylate—Erythema—Methylprednisolone—psoriatic arthritis	0.00531	0.00531	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisolone—psoriatic arthritis	0.00529	0.00529	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Dexamethasone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Betamethasone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisolone—psoriatic arthritis	0.00502	0.00502	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisolone—psoriatic arthritis	0.005	0.005	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisone—psoriatic arthritis	0.00492	0.00492	CcSEcCtD
Cisatracurium Besylate—Angioedema—Triamcinolone—psoriatic arthritis	0.00487	0.00487	CcSEcCtD
Cisatracurium Besylate—Angioedema—Methylprednisolone—psoriatic arthritis	0.00485	0.00485	CcSEcCtD
Cisatracurium Besylate—Erythema—Betamethasone—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Cisatracurium Besylate—Erythema—Dexamethasone—psoriatic arthritis	0.00483	0.00483	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00475	0.00475	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00473	0.00473	CcSEcCtD
Cisatracurium Besylate—Convulsion—Triamcinolone—psoriatic arthritis	0.00461	0.00461	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisolone—psoriatic arthritis	0.00461	0.00461	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methylprednisolone—psoriatic arthritis	0.0046	0.0046	CcSEcCtD
Cisatracurium Besylate—Hypertension—Triamcinolone—psoriatic arthritis	0.0046	0.0046	CcSEcCtD
Cisatracurium Besylate—Hypertension—Methylprednisolone—psoriatic arthritis	0.00459	0.00459	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Cisatracurium Besylate—Flushing—Prednisone—psoriatic arthritis	0.00449	0.00449	CcSEcCtD
Cisatracurium Besylate—Angioedema—Betamethasone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Cisatracurium Besylate—Angioedema—Dexamethasone—psoriatic arthritis	0.00441	0.00441	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Prednisone—psoriatic arthritis	0.00439	0.00439	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Prednisone—psoriatic arthritis	0.00437	0.00437	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00435	0.00435	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00434	0.00434	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.00425	0.00425	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Triamcinolone—psoriatic arthritis	0.00424	0.00424	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00423	0.00423	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Cisatracurium Besylate—Convulsion—Betamethasone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Cisatracurium Besylate—Convulsion—Dexamethasone—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Cisatracurium Besylate—Hypertension—Betamethasone—psoriatic arthritis	0.00417	0.00417	CcSEcCtD
Cisatracurium Besylate—Hypertension—Dexamethasone—psoriatic arthritis	0.00417	0.00417	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methylprednisolone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00394	0.00394	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Dexamethasone—psoriatic arthritis	0.00385	0.00385	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Betamethasone—psoriatic arthritis	0.00385	0.00385	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisone—psoriatic arthritis	0.00384	0.00384	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisolone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Cisatracurium Besylate—Hypotension—Dexamethasone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Cisatracurium Besylate—Hypotension—Betamethasone—psoriatic arthritis	0.00368	0.00368	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methotrexate—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methotrexate—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisone—psoriatic arthritis	0.00365	0.00365	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisone—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Cisatracurium Besylate—Erythema—Methotrexate—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00348	0.00348	CcSEcCtD
Cisatracurium Besylate—Urticaria—Triamcinolone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methylprednisolone—psoriatic arthritis	0.00344	0.00344	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Prednisone—psoriatic arthritis	0.00337	0.00337	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisone—psoriatic arthritis	0.00335	0.00335	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Prednisone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Cisatracurium Besylate—Urticaria—Dexamethasone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Cisatracurium Besylate—Urticaria—Betamethasone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Cisatracurium Besylate—Pruritus—Triamcinolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methylprednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methotrexate—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisolone—psoriatic arthritis	0.00298	0.00298	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Cisatracurium Besylate—Pruritus—Betamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Cisatracurium Besylate—Pruritus—Dexamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methotrexate—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Cisatracurium Besylate—Rash—Triamcinolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Triamcinolone—psoriatic arthritis	0.00274	0.00274	CcSEcCtD
Cisatracurium Besylate—Rash—Methylprednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methotrexate—psoriatic arthritis	0.00268	0.00268	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Methotrexate—psoriatic arthritis	0.00256	0.00256	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Cisatracurium Besylate—Rash—Betamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Cisatracurium Besylate—Rash—Dexamethasone—psoriatic arthritis	0.00249	0.00249	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Betamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Dexamethasone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Cisatracurium Besylate—Pruritus—Prednisone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methotrexate—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisone—psoriatic arthritis	0.00217	0.00217	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisone—psoriatic arthritis	0.00216	0.00216	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Cisatracurium Besylate—Rash—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methotrexate—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
